Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perinatal Health Promotion in Indigenous Maternal Health: A Scoping Review of Peer-Reviewed Evidence and Australian Community-Controlled Programs.

International journal of environmental research and public health·2026
Same author

Obstetric, sociodemographic, and clinical factors influencing C-section trends in Australia, from 2007 to 2017: An analysis of population-based perinatal data in Queensland using the Robson classification.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C study.

BMC infectious diseases·2025
Same author

Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort Study.

Canadian journal of kidney health and disease·2025
Same author

Prevalence of surgery in Indigenous people with cancer: a systematic review and meta-analysis.

The Lancet regional health. Western Pacific·2025
Same author

Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled Trial.

Journal of medical Internet research·2025

Related Experiment Video

Updated: May 26, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Mortality patterns in hypertension.

Hisatomi Arima1, Federica Barzi, John Chalmers

  • 1The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, NSW 2050 Australia.

Journal of Hypertension
|December 14, 2011
PubMed
Summary
This summary is machine-generated.

High blood pressure (hypertension) is a leading global cause of death, particularly in low-income countries. Effective strategies must combine community-level interventions with improved clinical treatments for hypertension.

Related Experiment Videos

Last Updated: May 26, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Area of Science:

  • Public Health
  • Cardiology
  • Epidemiology

Background:

  • Raised blood pressure (BP) is a significant global health issue, causing 7.6 million deaths annually and contributing to stroke and coronary heart disease.
  • The burden of high BP and cardiovascular mortality is disproportionately high in low and middle-income countries (LMIC).
  • Cardiovascular mortality continues to rise globally due to aging populations, even as age-specific rates decline in developed nations.

Purpose of the Study:

  • To highlight the global impact of raised blood pressure as a critical risk factor for mortality.
  • To emphasize the continuous relationship between blood pressure and cardiovascular death, extending below the traditional hypertension threshold.
  • To advocate for integrated strategies to reduce the burden of BP-related deaths.

Main Methods:

  • This study is a review and analysis of global mortality data related to blood pressure.
  • It examines the attributable risk of high BP for major cardiovascular events like stroke and coronary heart disease.
  • The analysis considers trends in both developed and LMIC, factoring in population demographics.

Main Results:

  • Raised blood pressure is the leading risk factor for global mortality, accounting for 13.5% of all deaths.
  • High BP is linked to 54% of stroke cases and 47% of coronary heart disease cases.
  • Even blood pressure levels below the hypertensive threshold contribute to cardiovascular mortality, underscoring hypertension as a 'silent killer'.

Conclusions:

  • Reducing the burden of BP-related deaths necessitates a dual approach: population-level strategies and enhanced clinical treatments.
  • Addressing hypertension requires interventions at both community and individual clinical levels.
  • The continuous relationship between BP and mortality necessitates broader management strategies beyond the traditional hypertensive threshold.